Medical Management of Acute Liver Failure

  • Heli Bhatt
  • Girish S. RaoEmail author


Pediatric acute liver failure is a rapidly progressive, life-threatening, and devastating illness in children without preexisting liver disease. Due to the rarity and heterogeneity of this syndrome, there is a significant lack of data to guide evaluation and management of this disease. Most of our practice is extrapolated from adult literature and guidelines. This leads to significant controversies in medical management of acute liver failure in children. With advances in critical care, there has been a tremendous improvement in outcomes with decreased morbidity and mortality; however, there is a dire need for more research in this field. This chapter discusses challenges as well as controversies in diagnostic evaluation and management of this rare but potentially fatal disease. Latest developments in supportive care of liver failure, including advances in the area of liver support systems, are also discussed.


Acute liver failure Pediatric Multi-organ system failure Hepatic encephalopathy Liver support systems Liver transplantation 


  1. 1.
    Wlodzimirow KA, Eslami S, Abu-Hanna A, Nieuwoudt M, Chamuleau RA. Systematic review: acute liver failure - one disease, more than 40 definitions. Aliment Pharmacol Ther. 2012;35(11):1245–56. Scholar
  2. 2.
    Rivera-Penera T, Moreno J, Skaff C, McDiarmid S, Vargas J, Ament ME. Delayed encephalopathy in fulminant hepatic failure in the pediatric population and the role of liver transplantation. J Pediatr Gastroenterol Nutr. 1997;24(2):128–34.CrossRefGoogle Scholar
  3. 3.
    Squires RH Jr, Shneider BL, Bucuvalas J, Alonso E, Sokol RJ, Narkewicz MR, et al. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr. 2006;148(5):652–8. Scholar
  4. 4.
    Lutfi R, Abulebda K, Nitu ME, Molleston JP, Bozic MA, Subbarao G. Intensive Care Management of Pediatric Acute Liver Failure. J Pediatr Gastroenterol Nutr. 2017;64(5):660–70. .
  5. 5.
    Squires RH Jr. Acute liver failure in children. Semin Liver Dis. 2008;28(2):153–66. Scholar
  6. 6.
    Kim WR, Lake JR, Smith JM, Skeans MA, Schladt DP, Edwards EB, et al. OPTN/SRTR 2015 annual data report: liver. Am J Transplant. 2017;17:174–251. Scholar
  7. 7.
    Sundaram SS, Alonso EM, Narkewicz MR, Zhang S, Squires RH. Characterization and outcomes of young infants with acute liver failure. J Pediatr. 2011;159(5):813–818.e1. Scholar
  8. 8.
    Narkewicz MR, Dell Olio D, Karpen SJ, Murray KF, Schwarz K, Yazigi N, et al. Pattern of diagnostic evaluation for the causes of pediatric acute liver failure: an opportunity for quality improvement. J Pediatr. 2009;155(6):801–6.e1. Scholar
  9. 9.
    Bhatt H, Rao GS. Management of Acute Liver Failure: a pediatric perspective. Curr Pediatr Rep. 2018;
  10. 10.
    Singhal A, Vadlamudi S, Stokes K, Cassidy FP, Corn A, Shrago SS, et al. Liver histology as predictor of outcome in patients with acute liver failure. Transpl Int. 2012;25(6):658–62. Scholar
  11. 11.
    Miraglia R, Luca A, Gruttadauria S, Minervini MI, Vizzini G, Arcadipane A, et al. Contribution of transjugular liver biopsy in patients with the clinical presentation of acute liver failure. Cardiovasc Intervent Radiol. 2006;29(6):1008–10. Scholar
  12. 12.
    Ostapowicz G, Fontana RJ, Schiodt FV, Larson A, Davern TJ, Han SH, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002;137(12):947–54.CrossRefGoogle Scholar
  13. 13.
    Scott TR, Kronsten VT, Hughes RD, Shawcross DL. Pathophysiology of cerebral oedema in acute liver failure. World J Gastroenterol. 2013;19(48):9240–55. Scholar
  14. 14.
    Bernal W, Hall C, Karvellas CJ, Auzinger G, Sizer E, Wendon J. Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure. Hepatology. 2007;46(6):1844–52. Scholar
  15. 15.
    Butterworth RF. The concept of "the inflamed brain" in acute liver failure: mechanisms and new therapeutic opportunities. Metab Brain Dis. 2016;31(6):1283–7. Scholar
  16. 16.
    Stravitz RT, Kramer AH, Davern T, Shaikh AO, Caldwell SH, Mehta RL, et al. Intensive care of patients with acute liver failure: recommendations of the U.S. acute liver failure study group. Crit Care Med. 2007;35(11):2498–508. .
  17. 17.
    Lee WM, Larson AM, Stravitz RT. AASLD position paper: the management of acute liver failure: update 2011. AASLD September. 2011.Google Scholar
  18. 18.
    Kodali S, McGuire BM. Diagnosis and Management of Hepatic Encephalopathy in fulminant hepatic failure. Clin Liver Dis. 2015;19(3):565–76. Scholar
  19. 19.
    Alba L, Hay JE, Angulo P, Lee WM. Lactulose therapy in acute liver failure. J Hepatol. 2002;36:33. Scholar
  20. 20.
    Stravitz RT, Gottfried M, Durkalski V, Fontana RJ, Hanje AJ, Koch D, et al. Safety, tolerability and pharmacokinetics of L-ornithine Phenylacetate in patients with acute liver injury/failure and Hyperammonemia. Hepatology. 2017;
  21. 21.
    Cardoso FS, Gottfried M, Tujios S, Olson JC, Karvellas CJ. Continuous renal replacement therapy is associated with reduced serum ammonia levels and mortality in acute liver failure. Hepatology. 2017;
  22. 22.
    Bucuvalas J, Yazigi N, Squires RH Jr. Acute liver failure in children. Clin Liver Dis. 2006;10(1):149–68., vii. Scholar
  23. 23.
    Vaquero J, Fontana RJ, Larson AM, Bass NM, Davern TJ, Shakil AO, et al. Complications and use of intracranial pressure monitoring in patients with acute liver failure and severe encephalopathy. Liver Transpl. 2005;11(12):1581–9. Scholar
  24. 24.
    Rajajee V, Fontana RJ, Courey AJ, Patil PG. Protocol based invasive intracranial pressure monitoring in acute liver failure: feasibility, safety and impact on management. Crit Care. 2017;21(1):178. Scholar
  25. 25.
    Kamat P, Kunde S, Vos M, Vats A, Gupta N, Heffron T, et al. Invasive intracranial pressure monitoring is a useful adjunct in the management of severe hepatic encephalopathy associated with pediatric acute liver failure. Pediatr Crit Care Med. 2012;13(1):e33–8. Scholar
  26. 26.
    Richardson D, Bellamy M. Intracranial hypertension in acute liver failure. Nephrol Dial Transplant. 2002;17(1):23–7.CrossRefGoogle Scholar
  27. 27.
    Murphy N, Auzinger G, Bernel W, Wendon J. The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure. Hepatology. 2004;39(2):464–70. Scholar
  28. 28.
    Bell MJ, Kochanek PM. Pediatric traumatic brain injury in 2012: the year with new guidelines and common data elements. Crit Care Clin. 2013;29(2):223–38. Scholar
  29. 29.
    Kochanek PM, Carney N, Adelson PD, Ashwal S, Bell MJ, Bratton S, et al. Guidelines for the acute medical management of severe traumatic brain injury in infants, children, and adolescents—second edition. Pediatr Crit Care Med. 2012;13(Suppl 1):S1–82. Scholar
  30. 30.
    Ede RJ, Gimson AES, Bihari D, Williams R. Controlled hyperventilation in the prevention of cerebral oedema in fulminant hepatic failure. J Hepatol. 1986;2(1):43–51. Scholar
  31. 31.
    Vaquero J. Therapeutic hypothermia in the management of acute liver failure. Neurochem Int. 2012;60(7):723–35. Scholar
  32. 32.
    Stravitz RT, Larsen FS. Therapeutic hypothermia for acute liver failure. Crit Care Med. 2009;37(7 Suppl):S258–64. Scholar
  33. 33.
    Karvellas CJ, Cavazos J, Battenhouse H, Durkalski V, Balko J, Sanders C, et al. Effects of antimicrobial prophylaxis and blood stream infections in patients with acute liver failure: a retrospective cohort study. Clin Gastroenterol Hepatol. 2014;12(11):1942–9.e1. Scholar
  34. 34.
    Hussain E, Grimason M, Goldstein J, Smith CM, Alonso E, Whitington PF, et al. EEG abnormalities are associated with increased risk of transplant or poor outcome in children with acute liver failure. J Pediatr Gastroenterol Nutr. 2014;58(4):449–56. Scholar
  35. 35.
    Ellis AJ, Wendon JA, Williams R. Subclinical seizure activity and prophylactic phenytoin infusion in acute liver failure: a controlled clinical trial. Hepatology. 2000;32(3):536–41. Scholar
  36. 36.
    Aggarwal S, Brooks DM, Kang Y, Linden PK, Patzer JF 2nd. Noninvasive monitoring of cerebral perfusion pressure in patients with acute liver failure using transcranial doppler ultrasonography. Liver Transpl. 2008;14(7):1048–57. Scholar
  37. 37.
    Bhatia V, Batra Y, Acharya SK. Prophylactic phenytoin does not improve cerebral edema or survival in acute liver failure—a controlled clinical trial. J Hepatol. 2004;41(1):89–96. Scholar
  38. 38.
    Basile AS, Hughes RD, Harrison PM, Murata Y, Pannell L, Jones EA, et al. Elevated brain concentrations of 1,4-benzodiazepines in fulminant hepatic failure. N Engl J Med. 1991;325(7):473–8. Scholar
  39. 39.
    Wijdicks EF, Nyberg SL. Propofol to control intracranial pressure in fulminant hepatic failure. Transplant Proc. 2002;34(4):1220–2.CrossRefGoogle Scholar
  40. 40.
    Cunningham FE, Baughman VL, Tonkovich L, Lam N, Layden T. Pharmacokinetics of Dexmedetomidine (DEX) in patients with hepatic failure (HF). Clin Pharmacol Ther. 1999;65(2):128. Scholar
  41. 41.
    Craig RG, Hunter JM. Neuromuscular blocking drugs and their antagonists in patients with organ disease. Anaesthesia. 2009;64(Suppl 1):55–65. Scholar
  42. 42.
    Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002;288(7):862–71.CrossRefPubMedGoogle Scholar
  43. 43.
    Marik PE, Gayowski T, Starzl TE. The hepatoadrenal syndrome: a common yet unrecognized clinical condition. Crit Care Med. 2005;33(6):1254–9.CrossRefPubMedGoogle Scholar
  44. 44.
    Annane D, Bellissant E, Sebille V, Lesieur O, Mathieu B, Raphael JC, et al. Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve. Br J Clin Pharmacol. 1998;46(6):589–97.CrossRefPubMedGoogle Scholar
  45. 45.
    Soltys KA, Mazariegos GV. Hepatoadrenal syndrome in critically ill children with liver failure: is it true, true, and unrelated? Pediatr Crit Care Med. 2012;13(3):366–7. Scholar
  46. 46.
    Hauser GJ, Brotzman HM, Kaufman SS. Hepatoadrenal syndrome in pediatric patients with end-stage liver disease. Pediatr Crit Care Med. 2012;13(3):e145–9. Scholar
  47. 47.
    Audimoolam VK, McPhail MJ, Wendon JA, Willars C, Bernal W, Desai SR, et al. Lung injury and its prognostic significance in acute liver failure. Crit Care Med. 2014;42(3):592–600. Scholar
  48. 48.
    Khemani RG, Smith LS, Zimmerman JJ, Erickson S. Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the pediatric acute lung injury consensus conference. Pediatr Crit Care Med. 2015;16(5 Suppl 1):S23–40. Scholar
  49. 49.
    Tujios SR, Hynan LS, Vazquez MA, Larson AM, Seremba E, Sanders CM, et al. Risk factors and outcomes of acute kidney injury in patients with acute liver failure. Clin Gastroenterol Hepatol. 2015;13(2):352–9. Scholar
  50. 50.
    Kulkarni S, Perez C, Pichardo C, Castillo L, Gagnon M, Beck-Sague C, et al. Use of pediatric health information system database to study the trends in the incidence, management, etiology, and outcomes due to pediatric acute liver failure in the United States from 2008 to 2013. Pediatr Transplant. 2015;19(8):888–95. Scholar
  51. 51.
    Moore JK, Love E, Craig DG, Hayes PC, Simpson KJ. Acute kidney injury in acute liver failure: a review. Expert Rev Gastroenterol Hepatol. 2013;7(8):701–12. Scholar
  52. 52.
    Leventhal TM, Liu KD. What a nephrologist needs to know about acute liver failure. Adv Chronic Kidney Dis. 2015;22(5):376–81. Scholar
  53. 53.
    Angeli P, Gines P, Wong F, Bernardi M, Boyer TD, Gerbes A, et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites. J Hepatol. 2015;62(4):968–74. Scholar
  54. 54.
    Fortenberry JD, Paden ML, Goldstein SL. Acute kidney injury in children: an update on diagnosis and treatment. Pediatr Clin N Am. 2013;60(3):669–88. Scholar
  55. 55.
    Davenport A. Continuous renal replacement therapy for liver disease. Hemodial Int. 2003;7(4):348–52. Scholar
  56. 56.
    Devarajan P. Emerging urinary biomarkers in the diagnosis of acute kidney injury. Expert Opin Med Diagn. 2008;2(4):387–98. Scholar
  57. 57.
    Nadim MK, Sung RS, Davis CL, Andreoni KA, Biggins SW, Danovitch GM, et al. Simultaneous liver-kidney transplantation summit: current state and future directions. Am J Transplant. 2012;12(11):2901–8. Scholar
  58. 58.
    Jalanko H, Pakarinen M. Combined liver and kidney transplantation in children. Pediatr Nephrol. 2014;29(5):805–14.; quiz 12. Scholar
  59. 59.
    Plauth M, Cabre E, Riggio O, Assis-Camilo M, Pirlich M, Kondrup J, et al. ESPEN guidelines on enteral nutrition: liver disease. Clin Nutr. 2006;25(2):285–94. Scholar
  60. 60.
    Plauth M, Cabre E, Campillo B, Kondrup J, Marchesini G, Schutz T, et al. ESPEN guidelines on parenteral nutrition: hepatology. Clin Nutr. 2009;28(4):436–44. Scholar
  61. 61.
    Schutz T, Bechstein WO, Neuhaus P, Lochs H, Plauth M. Clinical practice of nutrition in acute liver failure—a European survey. Clin Nutr. 2004;23(5):975–82. Scholar
  62. 62.
    Stravitz RT, Ellerbe C, Durkalski V, Schilsky M, Fontana RJ, Peterseim C, et al. Bleeding complications in acute liver failure. Hepatology. 2018;67(5):1931–42. Scholar
  63. 63.
    Stravitz RT, Lisman T, Luketic VA, Sterling RK, Puri P, Fuchs M, et al. Minimal effects of acute liver injury/acute liver failure on hemostasis as assessed by thromboelastography. J Hepatol. 2012;56(1):129–36. Scholar
  64. 64.
    Agarwal B, Wright G, Gatt A, Riddell A, Vemala V, Mallett S, et al. Evaluation of coagulation abnormalities in acute liver failure. J Hepatol. 2012;57(4):780–6. Scholar
  65. 65.
    Pereira SP, Rowbotham D, Fitt S, Shearer MJ, Wendon J, Williams R. Pharmacokinetics and efficacy of oral versus intravenous mixed-micellar phylloquinone (vitamin K1) in severe acute liver disease. J Hepatol. 2005;42(3):365–70. Scholar
  66. 66.
    Shami VM, Caldwell SH, Hespenheide EE, Arseneau KO, Bickston SJ, Macik BG. Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy. Liver Transpl. 2003;9(2):138–43. Scholar
  67. 67.
    Pavese P, Bonadona A, Beaubien J, Labrecque P, Pernod G, Letoublon C, et al. FVIIa corrects the coagulopathy of fulminant hepatic failure but may be associated with thrombosis: a report of four cases. Can J Anaesth. 2005;52(1):26–9. Scholar
  68. 68.
    Munoz SJ, Stravitz RT, Gabriel DA. Coagulopathy of acute liver failure. Clin Liver Dis. 2009;13(1):95–107. Scholar
  69. 69.
    Rolando N, Wade J, Davalos M, Wendon J, Philpott-Howard J, Williams R. The systemic inflammatory response syndrome in acute liver failure. Hepatology. 2000;32(4 Pt 1):734–9. Scholar
  70. 70.
    Rolando N, Harvey F, Brahm J, Philpott-Howard J, Alexander G, Gimson A, et al. Prospective study of bacterial infection in acute liver failure: an analysis of fifty patients. Hepatology. 1990;11(1):49–53.CrossRefGoogle Scholar
  71. 71.
    Godbole G, Shanmugam N, Dhawan A, Verma A. Infectious complications in pediatric acute liver failure. J Pediatr Gastroenterol Nutr. 2011;53(3):320–5. Scholar
  72. 72.
    Vaquero J, Polson J, Chung C, Helenowski I, Schiodt FV, Reisch J, et al. Infection and the progression of hepatic encephalopathy in acute liver failure. Gastroenterology. 2003;125(3):755–64.CrossRefGoogle Scholar
  73. 73.
    Struecker B, Raschzok N, Sauer IM. Liver support strategies: cutting-edge technologies. Nat Rev Gastroenterol Hepatol. 2014;11(3):166–76. Scholar
  74. 74.
    Rademacher S, Oppert M, Jorres A. Artificial extracorporeal liver support therapy in patients with severe liver failure. Expert Rev Gastroenterol Hepatol. 2011;5(5):591–9. Scholar
  75. 75.
    Chevret L, Durand P, Lambert J, Essouri S, Balu L, Devictor D, et al. High-volume hemofiltration in children with acute liver failure*. Pediatr Crit Care Med. 2014;15(7):e300–5. Scholar
  76. 76.
    Larsen FS, Schmidt LE, Bernsmeier C, Rasmussen A, Isoniemi H, Patel VC, et al. High-volume plasma exchange in patients with acute liver failure: an open randomised controlled trial. J Hepatol. 2016;64(1):69–78. Scholar
  77. 77.
    Singer AL, Olthoff KM, Kim H, Rand E, Zamir G, Shaked A. Role of plasmapheresis in the management of acute hepatic failure in children. Ann Surg. 2001;234(3):418–24.CrossRefPubMedGoogle Scholar
  78. 78.
    Khuroo MS, Khuroo MS, Farahat KL. Molecular adsorbent recirculating system for acute and acute-on-chronic liver failure: a meta-analysis. Liver Transpl. 2004;10(9):1099–106. Scholar
  79. 79.
    Saliba F, Camus C, Durand F, Mathurin P, Letierce A, Delafosse B, et al. Albumin dialysis with a noncell artificial liver support device in patients with acute liver failure: a randomized, controlled trial. Ann Intern Med. 2013;159(8):522–31. Scholar
  80. 80.
    Lexmond WS, Van Dael CM, Scheenstra R, Goorhuis JF, Sieders E, Verkade HJ, et al. Experience with molecular adsorbent recirculating system treatment in 20 children listed for high-urgency liver transplantation. Liver Transpl. 2015;21(3):369–80. Scholar
  81. 81.
    Demetriou AA, Brown RS Jr, Busuttil RW, Fair J, McGuire BM, Rosenthal P, et al. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg. 2004;239(5):660–7. discussion 7-70CrossRefPubMedGoogle Scholar
  82. 82.
    Jain V, Dhawan A. Extracorporeal liver support Systems in Paediatric Liver Failure. J Pediatr Gastroenterol Nutr. 2017;64(6):855–63. .
  83. 83.
    Squires RH, Ng V, Romero R, Ekong U, Hardikar W, Emre S, et al. Evaluation of the pediatric patient for liver transplantation: 2014 practice guideline by the American Association for the Study of Liver Diseases, American Society of Transplantation and the north American Society for Pediatric Gastroenterology, hepatology and nutrition. Hepatology. 2014;60(1):362–98. .
  84. 84.
    Baliga P, Alvarez S, Lindblad A, Zeng L. Posttransplant survival in pediatric fulminant hepatic failure: the SPLIT experience. Liver Transpl. 2004;10(11):1364–71. Scholar
  85. 85.
    Farmer DG, Venick RS, McDiarmid SV, Duffy JP, Kattan O, Hong JC, et al. Fulminant hepatic failure in children: superior and durable outcomes with liver transplantation over 25 years at a single center. Ann Surg. 2009;250(3):484–93. Scholar
  86. 86.
    Sundaram V, Shneider BL, Dhawan A, Ng VL, Im K, Belle S, et al. King’s college hospital criteria for non-acetaminophen induced acute liver failure in an international cohort of children. J Pediatr. 2013;162(2):319–23.e1. Scholar
  87. 87.
    Barshes NR, Lee TC, Udell IW, O’Mahoney CA, Karpen SJ, Carter BA, et al. The pediatric end-stage liver disease (PELD) model as a predictor of survival benefit and posttransplant survival in pediatric liver transplant recipients. Liver Transpl. 2006;12(3):475–80. Scholar
  88. 88.
    Lu BR, Zhang S, Narkewicz MR, Belle SH, Squires RH, Sokol RJ. Evaluation of the liver injury unit scoring system to predict survival in a multinational study of pediatric acute liver failure. J Pediatr. 2013;162(5):1010–6.e1-4. Scholar
  89. 89.
    Lu BR, Gralla J, Liu E, Dobyns EL, Narkewicz MR, Sokol RJ. Evaluation of a scoring system for assessing prognosis in pediatric acute liver failure. Clin Gastroenterol Hepatol. 2008;6(10):1140–5. Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Division of Pediatric Gastroenterology, Hepatology, and NutritionRiley Hospital for Children at Indiana University HealthIndianapolisUSA

Personalised recommendations